TenaTac®
Wound Care
Information
TenaTac® uses an innovative technology that enhances the adhesion of a conventional gelatine sponge to an area of surgical bleeding, ensuring that the product will remain in situ to maximise haemostatic control.
This novel technology has the potential to reduce postoperative bleeding complications. Selentus’ technology is based upon a unique surface modification in which no new materials are added.
Patents granted in Europe (EP3362110); U.K. (GB 2543307), U.S.A (US 10,653,821), Brazil (BR 112018007612-0 B1) and Japan (JP 6854825) and pending worldwide.
TenaTac® has a unique surface modification created with high precision. The surface of the patch is divided into over 1000 columns. This leads to a 10-fold increase in surface area, greatly increasing the interaction between the product and the underlying tissue.
The flexible columns conform to the variations in tissue surface and act independently to resist
shear forces that may dislodge a normal sponge in the perioperative period.
TenaTac® becomes pliable when moist and compresses to 1-2mm. Its flexibility in dry form can be improved by light compression thus facilitating minimal invasive application.